Biotech, FDAFDA Issues Complete Response Letter to Fortress Biotech's Menkes Disease Drug CUTX-101 Due to Manufacturing Deficiencies100% left coverage1 source
Biotech, FDAFDA Issues Complete Response Letter to Fortress Biotech's Menkes Disease Drug CUTX-101 Due to Manufacturing Deficiencies100% left coverage1 source
Biotech, MarketsIO Biotech Faces FDA Rejection of Cylembio, Plans New Melanoma Study, Cuts Workforce 50%50% center coverage2 sources
Biotech, MarketsIO Biotech Faces FDA Rejection of Cylembio, Plans New Melanoma Study, Cuts Workforce 50%50% center coverage2 sources
Biotech, FDAFederal Judge Allows BioXcel Shareholders Amended Suit Over FDA Trial Compliance50% center coverage2 sources
Biotech, FDAFederal Judge Allows BioXcel Shareholders Amended Suit Over FDA Trial Compliance50% center coverage2 sources
Biotech, MarketsMoore Nanotechnology Systems Named 25th Best Company to Work For in 2025100% left coverage1 source
Biotech, MarketsMoore Nanotechnology Systems Named 25th Best Company to Work For in 2025100% left coverage1 source
Biotech, FDAFDA Expands Krystal Biotech Gene Therapy Label for DEB from Birth100% left coverage1 source
Biotech, FDAFDA Expands Krystal Biotech Gene Therapy Label for DEB from Birth100% left coverage1 source